LLY icon

Eli Lilly (LLY)

NYSE

$991.20

$24.04 (

+2.49%

)

1D
5D
1M
6M
1Y
5Y
Market open

LLY: $991.20 / ₿ 0.0123 BTC / 1230861 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$967.16
$623.78 - $1,133.95
$883.90B
34.99
$974.44
$1,622,415.18
891.74M
34.35
$990.85 - $991.67
0.72
$971.61 - $997.52
Yes

What is Eli Lilly (LLY)?

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

The Eli Lilly (LLY) stock price has been rising

The Eli Lilly & Co. (LLY) stock price today is $991.20, reflecting a +2.49% move since the market opened. The company’s market capitalization stands at $883.90B, with a daily trading volume of $1.62M shares. For investors tracking price trends, Eli Lilly & Co. stock has ranged between $971.61 and $997.52 today. The previous closing price was $967.16.

Get started with Eli Lilly (LLY)

Ready to get started? Follow the steps below, or read our guide on how to buy Eli Lilly stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy LLY

Search for LLY in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy LLY.

LLY FAQs

LLY is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

LLY is in the Drug Manufacturers - General industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Eli Lilly & Co. (LLY) has traded between a low of $623.78 and a high of $1,133.95.

LLY is in the Drug Manufacturers industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

LLY’s payout ratio is 0.22. Payout ratio is a financial metric used to measure the proportion of a company's earnings that are paid out as dividends to shareholders.

LLY’s trailing dividend yield is 0.64. Trailing dividend yield is a financial metric used to measure the return on investment from a company's dividend payments over the past 12 months.

Want to invest in Eli Lilly? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
LLY icon
LLY

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

BZFDW icon

BZFDW

BZFD icon

BZFD

TDIC icon

TDIC

Top losers

Compare the worst-performing stocks of 
the day

OPITQ icon

OPITQ

YOTAR icon

YOTAR

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.